Skip to main content

Peer Review reports

From: NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Original Submission
4 Mar 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Author responded Author comments
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
4 Jul 2016 Editorially accepted
2 Sep 2016 Article published 10.1186/s12885-016-2671-9

You can find further information about peer review here.

Back to article page